BARNES JEFFREY T

CIK 00012612944 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001261294

Recent Transactions

30 trades

Conversion
AVALON PHARMACEUTICALS INC
8% Convertible Notes
2005-10-04−649→ 0 total
Conversion
AVALON PHARMACEUTICALS INC
8% Convertible Notes
2005-10-04−7,786→ 0 total
Conversion
AVALON PHARMACEUTICALS INC
8% Convertible Notes
2005-10-04−54,628→ 0 total
Conversion
AVALON PHARMACEUTICALS INC
Common Stock
2005-10-04+43,606→ 50,168 total
Conversion
AVALON PHARMACEUTICALS INC
Common Stock
2005-10-04+457,946→ 528,066 total
Conversion
AVALON PHARMACEUTICALS INC
Series A Redeemable Convertible Preferred Stock
2005-10-04−21,415→ 0 total
Conversion
AVALON PHARMACEUTICALS INC
Series A Redeemable Convertible Preferred Stock
2005-10-04−150,257→ 0 total
Conversion
AVALON PHARMACEUTICALS INC
Series A Redeemable Convertible Preferred Stock
2005-10-04−14,062→ 0 total
Conversion
AVALON PHARMACEUTICALS INC
Series B Redeemable Convertible Preferred Stock
2005-10-04−253,061→ 0 total
Conversion
AVALON PHARMACEUTICALS INC
Series A Redeemable Convertible Preferred Stock
2005-10-04−1,766→ 0 total
Conversion
AVALON PHARMACEUTICALS INC
Series B Redeemable Convertible Preferred Stock
2005-10-04−36,066→ 0 total
Purchase
AVALON PHARMACEUTICALS INC
Common Stock
2005-10-04$10.50/sh+20,693→ 95,954 total
Purchase
AVALON PHARMACEUTICALS INC
Common Stock
2005-10-04$10.50/sh+145,195→ 673,261 total
Purchase
AVALON PHARMACEUTICALS INC
Common Stock
2005-10-04$10.50/sh+1,717→ 7,961 total
Conversion
AVALON PHARMACEUTICALS INC
Common Stock
2005-10-04+65,267→ 75,261 total
Conversion
AVALON PHARMACEUTICALS INC
Series B Redeemable Convertible Preferred Stock
2005-10-04−23,686→ 0 total
Conversion
AVALON PHARMACEUTICALS INC
Series B Redeemable Convertible Preferred Stock
2005-10-04−3,005→ 0 total
Conversion
AVALON PHARMACEUTICALS INC
Common Stock
2005-10-04+5,420→ 6,244 total
Purchase
AVALON PHARMACEUTICALS INC
Common Stock
2005-10-04$10.50/sh+13,795→ 63,963 total
Conversion
AVALON PHARMACEUTICALS INC
8% Convertible Notes
2005-10-04−5,858→ 0 total
Award
Solexa, Inc.
Common
2005-07-12+20→ 30,255 total
Purchase
Solexa, Inc.
Warrant (right to buy)
2005-07-12+272,268→ 272,268 total
Purchase
Solexa, Inc.
Common
2005-07-12$4.00/sh+544,536→ 3,013,522 total
Purchase
Solexa, Inc.
Common
2005-07-12$4.00/sh+5,464→ 30,235 total
Purchase
Solexa, Inc.
Warrant (right to buy)
2005-07-12+2,732→ 2,732 total
Award
Solexa, Inc.
Common
2005-07-12+1,986→ 3,015,508 total
Purchase
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock Warrant (right to buy)
2005-04-20+146,600→ 146,600 total
Purchase
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2005-04-20$6.82/sh+586,402→ 3,160,238 total
Purchase
Cyberkinetics Neurotechnology Systems, Inc.
Common Stock
2004-11-04$3.00/sh+315,337→ 7,135,795 total
Purchase
Cyberkinetics Neurotechnology Systems, Inc.
Common Stock
2004-11-04$3.00/sh+3,164→ 71,595 total

Companies

Recent Filings

4
AVALON PHARMACEUTICALS INC
Oct 6, 2005

Address

222 BERKELEY ST.

BOSTON, MA, 02116

View on SEC.gov